XML 25 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements
6 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
As of the dates presented, we had assets on our consolidated balance sheets that were required to be measured at fair value on a recurring or non-recurring basis. We use a fair value hierarchy that requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value as follows:
Level 1 – Quoted prices in active markets for identical assets or liabilities;
Level 2 – Inputs other than quoted prices included in Level 1 that are observable either directly or indirectly through corroboration with market data; and
Level 3 – Unobservable inputs that reflect our own estimates about the assumptions market participants would use in pricing the asset or liability.
Certain of our assets are required to be recorded at fair value on a recurring basis. The fair value of our deferred compensation plan assets is based on market-corroborated inputs (Level 2).
Certain of our assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value of these assets may not be recovered. We review our long-lived assets, including inventory, for recoverability when factors indicate an impairment may exist, but no less than quarterly. Fair value of assets deemed to be impaired is determined based upon the type of asset being evaluated. The fair value of our owned inventory assets, when required to be calculated, is discussed within Notes 2 and 5. The fair value of our investments in unconsolidated entities is determined primarily using a discounted cash flow model to value the underlying net assets of the respective entities. Due to the substantial use of unobservable inputs in valuing the assets on a non-recurring basis, they are classified within Level 3.
Determining which hierarchical level an asset or liability falls within requires significant judgment. We evaluate our hierarchy disclosures each quarter.
The following table presents the period-end balances of assets measured at fair value on a recurring basis and the impairment-date fair value of certain assets measured at fair value on a non-recurring basis for each hierarchy level. These balances represent only those assets whose carrying values were adjusted to fair value during the periods presented:
(In thousands)
Level 1
 
Level 2
 
Level 3
 
Total
As of March 31, 2018
 
 
 
 
 
 
 
Deferred compensation plan assets (a)
$

 
$
1,445

 
$

 
$
1,445

Land held for sale (b)

 

 
642

 
642

As of September 30, 2017
 
 
 
 
 
 
 
Deferred compensation plan assets (a)
$

 
$
1,114

 
$

 
$
1,114

Development projects in progress (b)

 

 
3,791

 
3,791

Land held for sale (b)

 

 
325

 
325


(a) Measured at fair value on a recurring basis.
(b) Measured at fair value on a non-recurring basis.

The fair value of our cash and cash equivalents, restricted cash, accounts receivable, trade accounts payable, other liabilities, amounts due under the Facility (if outstanding), and other secured notes payable approximate their carrying amounts due to the short maturity of these assets and liabilities. When outstanding, obligations related to land not owned under option agreements approximate fair value.
The following table presents the carrying value and estimated fair value of certain of our other financial liabilities as of March 31, 2018 and September 30, 2017:
 
As of March 31, 2018
 
As of September 30, 2017
 (In thousands)
Carrying
Amount
(a)
 
Fair Value
 
Carrying
Amount
(a)
 
Fair Value
Senior Notes (b)
$
1,258,348

 
$
1,275,856

 
$
1,259,840

 
$
1,355,657

Junior Subordinated Notes
62,970

 
62,970

 
61,937

 
61,937

 
$
1,321,318

 
$
1,338,826

 
$
1,321,777

 
$
1,417,594


(a) Carrying amounts are net of unamortized debt premiums, debt issuance costs, and accretion.
(b) The estimated fair value for our publicly-held Senior Notes has been determined using quoted market rates (Level 2).